1. INTRODUCTION
1.1. MARKET DEFINITION
1.2. MARKET SEGMENTATION
1.3. PRODUCT OVERVIEW
2. ASSUMPTIONS AND ACRONYMS
3. RESEARCH METHODOLOGY
3.1. VARIABLES (DEPENDENT AND INDEPENDENT)
3.2. MULTI FACTOR BASED SENSITIVITY MODEL
4. EXECUTIVE SUMMARY - GLOBAL HEMATOLOGY DIAGNOSTICS MARKET
5. KEY MARKET OPPORTUNITIES
6. REGULATORY LANDSCAPE
7. LIST OF DEVICES
7.1. HEMATOLOGY DIAGNOSTICS
7.2. COMPANION DIAGNOSTICS
8. OVERVIEW OF APPLICATIONS OF COMPANION DIAGNOSTICS IN PHARMACODYNAMICS/PHARMACOKINETICS
9. ANALYSIS OF MARKET DYNAMICS
9.1. DRIVERS
9.2. RESTRAINTS
9.3. TRENDS
10. MARKET RISK ANALYSIS
10.1. DEMAND RISK ANALYSIS
10.2. SUPPLY RISK ANALYSIS
11. GLOBAL HEMATOLOGY DIAGNOSTICS MARKET OUTLOOK
11.1. MARKET SIZE AND FORECAST, 2018-2027
11.1.1. BY VALUE (USD MILLION)
11.2.GLOBAL HEMATOLOGY DIAGNOSTICS MARKET SEGMENTATION, 2018-2027
11.2.1. BY PRODUCT
o REAGENTS, INSTRUMENTS & ANALYZERS AND SOFTWARE & SERVICES, 2018-2027F (USD MILLION)
11.2.2. BY PORTABILITY
o POINT-OF-CARE (POC) DEVICES AND STANDALONE, 2018-2027F (USD MILLION)
11.2.3. BY APPLICATIONS
o ONCOLOGY, MALARIA, ANEMIA, BOOD COUNT, PLATELET FUNCTION, AND OTHERS (HIV, DIABETES, RARE GENETIC DISORDERS), 2018-2027F (USD MILLION)
·ANEMIA: SICKLE CELL ANEMIA, THALASSEMIA AND OTHERS (VITAMIN DEFICIENCY ANEMIA, IRON DEFICIENCY ANEMIA), 2018-2027F (USD MILLION)
11.2.4. BY END USER
o HOSPITALS, DIAGNOSTIC LABS, AMBULATORY SURGICAL CENTERS, CLINICS AND OTHERS (RESEARCH & EDUCATIONAL INSTITUTES), 2018-2027F (USD MILLION)
12. NORTH AMERICA HEMATOLOGY DIAGNOSTICS MARKET OUTLOOK
12.1.MARKET SIZE AND FORECAST, 2018-2027
12.1.1. BY VALUE (USD MILLION)
12.2. MACROECONOMIC INDICATORS, BY COUNTRY
12.3. NORTH AMERICA HEMATOLOGY DIAGNOSTICS MARKET SEGMENTATION, 2018-2027
12.3.1. BY PRODUCT
o REAGENTS, INSTRUMENTS & ANALYZERS AND SOFTWARE & SERVICES, 2018-2027F (USD MILLION)
12.3.2.BY PORTABILITY
o POINT-OF-CARE (POC) DEVICES AND STANDALONE, 2018-2027F (USD MILLION)
12.3.3.BY APPLICATIONS
o ONCOLOGY, MALARIA, ANEMIA, BOOD COUNT, PLATELET FUNCTION, AND OTHERS (HIV, DIABETES, RARE GENETIC DISORDERS), 2018-2027F (USD MILLION)
·ANEMIA: SICKLE CELL ANEMIA, THALASSEMIA AND OTHERS (VITAMIN DEFICIENCY ANEMIA, IRON DEFICIENCY ANEMIA), 2018-2027F (USD MILLION)
12.3.4.BY END USER
o HOSPITALS, DIAGNOSTIC LABS, AMBULATORY SURGICAL CENTERS, CLINICS AND OTHERS (RESEARCH & EDUCATIONAL INSTITUTES), 2018-2027F (USD MILLION)
12.3.5.BY COUNTRY
o US AND CANADA, 2018-2027F (USD MILLION)
13. EUROPE HEMATOLOGY DIAGNOSTICS MARKET OUTLOOK
13.1.MARKET SIZE AND FORECAST, 2018-2027
13.1.1. BY VALUE (USD MILLION)
13.2. MACROECONOMIC INDICATORS, BY COUNTRY
13.3. EUROPE HEMATOLOGY DIAGNOSTICS MARKET SEGMENTATION, 2018-2027
13.3.1. BY PRODUCT
o REAGENTS, INSTRUMENTS & ANALYZERS AND SOFTWARE & SERVICES, 2018-2027F (USD MILLION)
13.3.2.BY PORTABILITY
oPOINT-OF-CARE (POC) DEVICES AND STANDALONE, 2018-2027F (USD MILLION)
13.3.3.BY APPLICATIONS
o ONCOLOGY, MALARIA, ANEMIA, BOOD COUNT, PLATELET FUNCTION, AND OTHERS (HIV, DIABETES, RARE GENETIC DISORDERS), 2018-2027F (USD MILLION)
·ANEMIA: SICKLE CELL ANEMIA, THALASSEMIA AND OTHERS (VITAMIN DEFICIENCY ANEMIA, IRON DEFICIENCY ANEMIA), 2018-2027F (USD MILLION)
13.3.4.BY END USER
o HOSPITALS, DIAGNOSTIC LABS, AMBULATORY SURGICAL CENTERS, CLINICS AND OTHERS (RESEARCH & EDUCATIONAL INSTITUTES), 2018-2027F (USD MILLION)
13.3.5.BY COUNTRY
o UK, GERMANY, FRANCE, ITALY, RUSSIA, SPAIN, AND REST OF EUROPE, 2018-2027F (USD MILLION)
14. ASIA PACIFIC HEMATOLOGY DIAGNOSTICS MARKET OUTLOOK
14.1.MARKET SIZE AND FORECAST, 2018-2027
14.1.1. BY VALUE (USD MILLION)
14.2. MACROECONOMIC INDICATORS, BY COUNTRY
14.3. ASIA PACIFIC HEMATOLOGY DIAGNOSTICS MARKET SEGMENTATION, 2018-2027
14.3.1. BY PRODUCT
o REAGENTS, INSTRUMENTS & ANALYZERS AND SOFTWARE & SERVICES, 2018-2027F (USD MILLION)
14.3.2.BY PORTABILITY
o POINT-OF-CARE (POC) DEVICES AND STANDALONE, 2018-2027F (USD MILLION)
14.3.3.BY APPLICATIONS
o ONCOLOGY, MALARIA, ANEMIA, BOOD COUNT, PLATELET FUNCTION, AND OTHERS (HIV, DIABETES, RARE GENETIC DISORDERS), 2018-2027F (USD MILLION)
·ANEMIA: SICKLE CELL ANEMIA, THALASSEMIA AND OTHERS (VITAMIN DEFICIENCY ANEMIA, IRON DEFICIENCY ANEMIA), 2018-2027F (USD MILLION)
14.3.4.BY END USER
o HOSPITALS, DIAGNOSTIC LABS, AMBULATORY SURGICAL CENTERS, CLINICS AND OTHERS (RESEARCH & EDUCATIONAL INSTITUTES), 2018-2027F (USD MILLION)
14.3.5.BY COUNTRY
o CHINA, INDIA, JAPAN, MALAYSIA, SOUTH KOREA, AUSTRALIA, AND REST OF ASIA PACIFIC, 2018-2027F (USD MILLION)
15. LATIN AMERICA HEMATOLOGY DIAGNOSTICS MARKET OUTLOOK
15.1.MARKET SIZE AND FORECAST, 2018-2027
15.1.1. BY VALUE (USD MILLION)
15.2. MACROECONOMIC INDICATORS, BY COUNTRY
15.3. LATIN AMERICA HEMATOLOGY DIAGNOSTICS MARKET SEGMENTATION, 2018-2027
15.3.1. BY PRODUCT
o REAGENTS, INSTRUMENTS & ANALYZERS AND SOFTWARE & SERVICES, 2018-2027F (USD MILLION)
15.3.2.BY PORTABILITY
o POINT-OF-CARE (POC) DEVICES AND STANDALONE, 2018-2027F (USD MILLION)
15.3.3.BY APPLICATIONS
o ONCOLOGY, MALARIA, ANEMIA, BOOD COUNT, PLATELET FUNCTION, AND OTHERS (HIV, DIABETES, RARE GENETIC DISORDERS), 2018-2027F (USD MILLION)
·ANEMIA: SICKLE CELL ANEMIA, THALASSEMIA AND OTHERS (VITAMIN DEFICIENCY ANEMIA, IRON DEFICIENCY ANEMIA), 2018-2027F (USD MILLION)
15.3.4.BY END USER
o HOSPITALS, DIAGNOSTIC LABS, AMBULATORY SURGICAL CENTERS, CLINICS AND OTHERS (RESEARCH & EDUCATIONAL INSTITUTES), 2018-2027F (USD MILLION)
15.3.5.BY COUNTRY
o MEXICO, BRAZIL AND REST OF LATIN AMERICA, 2018-2027F (USD MILLION)
16. MIDDLE EAST & AFRICA HEMATOLOGY DIAGNOSTICS MARKET OUTLOOK
16.1.MARKET SIZE AND FORECAST, 2018-2027
16.1.1. BY VALUE (USD MILLION)
16.2. MACROECONOMIC INDICATORS, BY COUNTRY
16.3. MIDDLE EAST & AFRICA HEMATOLOGY DIAGNOSTICS MARKET SEGMENTATION, 2018-2027
16.3.1. BY PRODUCT
o REAGENTS, INSTRUMENTS & ANALYZERS AND SOFTWARE & SERVICES, 2018-2027F (USD MILLION)
16.3.2.BY PORTABILITY
o POINT-OF-CARE (POC) DEVICES AND STANDALONE, 2018-2027F (USD MILLION)
16.3.3.BY APPLICATIONS
o ONCOLOGY, MALARIA, ANEMIA, BOOD COUNT, PLATELET FUNCTION, AND OTHERS (HIV, DIABETES, RARE GENETIC DISORDERS), 2018-2027F (USD MILLION)
·ANEMIA: SICKLE CELL ANEMIA, THALASSEMIA AND OTHERS (VITAMIN DEFICIENCY ANEMIA, IRON DEFICIENCY ANEMIA), 2018-2027F (USD MILLION)
16.3.4.BY END USER
o HOSPITALS, DIAGNOSTIC LABS, AMBULATORY SURGICAL CENTERS, CLINICS AND OTHERS (RESEARCH & EDUCATIONAL INSTITUTES), 2018-2027F (USD MILLION)
16.3.5.BY COUNTRY
o ISRAEL, SOUTH AFRICA, SAUDI ARABIA, UAE, AND REST OF MIDDLE EAST & AFRICA, 2018-2027F (USD MILLION)
17. COMPETITIVE STRUCTURE
17.1. DETAILED OVERVIEW
17.2. ASSESSMENT OF KEY PRODUCT OFFERINGS
17.3. ANALYSIS OF GROWTH STRATEGIES
17.4. EXHAUSTIVE ANALYSIS ON KEY FINACIAL INDICATORS
17.5. REGIONAL PRESENCE
17.6. KEY PARTNERS AND COLLABORATIONS
17.7. RECENT NEWS AND DEVELOPMENTS
17.8. COMPANY PROFILES
o ABBOTT
o SYSMEX
o BECKMAN COULTER, INC.
o SIEMENS HEALTHCARE GMBH
o BOULE DIAGNOSTICS AB
o F. HOFFMANN-LA ROCHE LTD
o SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
o BIO-RAD LABORATORIES, INC.
o CELLAVISION
o OTHER PROMINENT PLAYERS
18. STRATEGIC RECOMMENDATIONS
